vs

Side-by-side financial comparison of National Vision Holdings, Inc. (EYE) and Rollins, Inc. (ROL). Click either name above to swap in a different company.

Rollins, Inc. is the larger business by last-quarter revenue ($906.4M vs $487.3M, roughly 1.9× National Vision Holdings, Inc.). Rollins, Inc. runs the higher net margin — 11.9% vs 0.7%, a 11.2% gap on every dollar of revenue. On growth, Rollins, Inc. posted the faster year-over-year revenue change (10.2% vs 7.9%). Rollins, Inc. produced more free cash flow last quarter ($111.2M vs $30.3M). Over the past eight quarters, National Vision Holdings, Inc.'s revenue compounded faster (7.6% CAGR vs 0.8%).

Vision Research is an international company that manufactures high-speed digital cameras based in Wayne, New Jersey. Their cameras are marketed under the Phantom brand, and are used in a broad variety of industries including: defense, industrial product development, manufacturing, automotive, scientific research, and entertainment. Vision Research is a business unit of the Materials Analysis Division of Ametek Inc., a global manufacturer of electronic instruments and electromechanical devices.

Rollins, Inc. is a North American pest control company serving residential and commercial clients. Operating globally through its wholly owned subsidiaries, Orkin, Inc., PCO Services, HomeTeam Pest Defense, Western Pest Services, Industrial Fumigant Company, TruTech, Critter Control, Crane, Waltham, OPC Services, PermaTreat, Northwest Exterminating, McCall Service and Clark Pest Control, as well UK subsidiaries Integrated Pest Management Limited, Safeguard Pest Control, NBC Environment, Europ...

EYE vs ROL — Head-to-Head

Bigger by revenue
ROL
ROL
1.9× larger
ROL
$906.4M
$487.3M
EYE
Growing faster (revenue YoY)
ROL
ROL
+2.3% gap
ROL
10.2%
7.9%
EYE
Higher net margin
ROL
ROL
11.2% more per $
ROL
11.9%
0.7%
EYE
More free cash flow
ROL
ROL
$81.0M more FCF
ROL
$111.2M
$30.3M
EYE
Faster 2-yr revenue CAGR
EYE
EYE
Annualised
EYE
7.6%
0.8%
ROL

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
EYE
EYE
ROL
ROL
Revenue
$487.3M
$906.4M
Net Profit
$3.4M
$107.8M
Gross Margin
Operating Margin
2.0%
16.1%
Net Margin
0.7%
11.9%
Revenue YoY
7.9%
10.2%
Net Profit YoY
139.8%
2.5%
EPS (diluted)
$0.04
$0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EYE
EYE
ROL
ROL
Q1 26
$906.4M
Q4 25
$912.9M
Q3 25
$487.3M
$1.0B
Q2 25
$486.4M
$999.5M
Q1 25
$510.3M
$822.5M
Q4 24
$437.3M
$832.2M
Q3 24
$451.5M
$916.3M
Q2 24
$451.7M
$891.9M
Net Profit
EYE
EYE
ROL
ROL
Q1 26
$107.8M
Q4 25
$116.4M
Q3 25
$3.4M
$163.5M
Q2 25
$8.7M
$141.5M
Q1 25
$14.2M
$105.2M
Q4 24
$-28.6M
$105.7M
Q3 24
$-8.5M
$136.9M
Q2 24
$-3.1M
$129.4M
Operating Margin
EYE
EYE
ROL
ROL
Q1 26
16.1%
Q4 25
17.5%
Q3 25
2.0%
21.9%
Q2 25
3.4%
19.8%
Q1 25
5.1%
17.3%
Q4 24
-5.8%
18.1%
Q3 24
-2.0%
20.9%
Q2 24
0.1%
20.4%
Net Margin
EYE
EYE
ROL
ROL
Q1 26
11.9%
Q4 25
12.8%
Q3 25
0.7%
15.9%
Q2 25
1.8%
14.2%
Q1 25
2.8%
12.8%
Q4 24
-6.5%
12.7%
Q3 24
-1.9%
14.9%
Q2 24
-0.7%
14.5%
EPS (diluted)
EYE
EYE
ROL
ROL
Q1 26
$0.22
Q4 25
$0.24
Q3 25
$0.04
$0.34
Q2 25
$0.11
$0.29
Q1 25
$0.18
$0.22
Q4 24
$-0.36
$0.22
Q3 24
$-0.11
$0.28
Q2 24
$-0.04
$0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EYE
EYE
ROL
ROL
Cash + ST InvestmentsLiquidity on hand
$56.0M
$116.5M
Total DebtLower is stronger
$236.5M
$650.6M
Stockholders' EquityBook value
$858.8M
$1.4B
Total Assets
$2.0B
$3.2B
Debt / EquityLower = less leverage
0.28×
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EYE
EYE
ROL
ROL
Q1 26
$116.5M
Q4 25
$100.0M
Q3 25
$56.0M
$127.4M
Q2 25
$48.5M
$123.0M
Q1 25
$80.0M
$201.2M
Q4 24
$73.9M
$89.6M
Q3 24
$81.2M
$95.3M
Q2 24
$179.5M
$106.7M
Total Debt
EYE
EYE
ROL
ROL
Q1 26
$650.6M
Q4 25
$486.1M
Q3 25
$236.5M
$485.7M
Q2 25
$255.6M
$485.3M
Q1 25
$244.7M
$485.5M
Q4 24
$248.6M
$395.3M
Q3 24
$252.8M
Q2 24
$143.9M
Stockholders' Equity
EYE
EYE
ROL
ROL
Q1 26
$1.4B
Q4 25
$1.4B
Q3 25
$858.8M
$1.5B
Q2 25
$850.6M
$1.4B
Q1 25
$836.2M
$1.4B
Q4 24
$816.3M
$1.3B
Q3 24
$840.0M
$1.3B
Q2 24
$843.4M
$1.2B
Total Assets
EYE
EYE
ROL
ROL
Q1 26
$3.2B
Q4 25
$3.1B
Q3 25
$2.0B
$3.2B
Q2 25
$2.0B
$3.2B
Q1 25
$2.0B
$2.9B
Q4 24
$2.0B
$2.8B
Q3 24
$2.0B
$2.8B
Q2 24
$2.1B
$2.8B
Debt / Equity
EYE
EYE
ROL
ROL
Q1 26
0.47×
Q4 25
0.35×
Q3 25
0.28×
0.32×
Q2 25
0.30×
0.34×
Q1 25
0.29×
0.36×
Q4 24
0.30×
0.30×
Q3 24
0.30×
Q2 24
0.17×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EYE
EYE
ROL
ROL
Operating Cash FlowLast quarter
$46.6M
$118.4M
Free Cash FlowOCF − Capex
$30.3M
$111.2M
FCF MarginFCF / Revenue
6.2%
12.3%
Capex IntensityCapex / Revenue
3.4%
0.8%
Cash ConversionOCF / Net Profit
13.83×
1.10×
TTM Free Cash FlowTrailing 4 quarters
$83.0M
$621.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EYE
EYE
ROL
ROL
Q1 26
$118.4M
Q4 25
$164.7M
Q3 25
$46.6M
$191.3M
Q2 25
$54.3M
$175.1M
Q1 25
$32.2M
$146.9M
Q4 24
$30.3M
$188.2M
Q3 24
$27.9M
$146.9M
Q2 24
$51.5M
$145.1M
Free Cash Flow
EYE
EYE
ROL
ROL
Q1 26
$111.2M
Q4 25
$159.0M
Q3 25
$30.3M
$182.8M
Q2 25
$42.4M
$168.0M
Q1 25
$12.0M
$140.1M
Q4 24
$-1.7M
$184.0M
Q3 24
$4.1M
$139.4M
Q2 24
$31.9M
$136.4M
FCF Margin
EYE
EYE
ROL
ROL
Q1 26
12.3%
Q4 25
17.4%
Q3 25
6.2%
17.8%
Q2 25
8.7%
16.8%
Q1 25
2.4%
17.0%
Q4 24
-0.4%
22.1%
Q3 24
0.9%
15.2%
Q2 24
7.1%
15.3%
Capex Intensity
EYE
EYE
ROL
ROL
Q1 26
0.8%
Q4 25
0.6%
Q3 25
3.4%
0.8%
Q2 25
2.4%
0.7%
Q1 25
4.0%
0.8%
Q4 24
7.3%
0.5%
Q3 24
5.3%
0.8%
Q2 24
4.3%
1.0%
Cash Conversion
EYE
EYE
ROL
ROL
Q1 26
1.10×
Q4 25
1.41×
Q3 25
13.83×
1.17×
Q2 25
6.22×
1.24×
Q1 25
2.27×
1.40×
Q4 24
1.78×
Q3 24
1.07×
Q2 24
1.12×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons